PULMONX CORP (LUNG) Forecast, Price Target & Analyst Ratings

NASDAQ:LUNG • US7458481014

Current stock price

1.17 USD
-0.07 (-5.65%)
At close:
1.17 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PULMONX CORP (LUNG).

Forecast Snapshot

Consensus Price Target

Price Target
$5.27
+ 350.43% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 28, 2026
Period
Q1 / 2026
EPS Estimate
-$0.33
Revenue Estimate
20.841M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.27
Upside
+ 350.43%
From current price of $1.17 to mean target of $5.27, Based on 12 analyst forecasts
Low
$2.53
Median
$3.57
High
$14.70

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for LUNG. The average price target is 5.27 USD. This implies a price increase of 350.43% is expected in the next year compared to the current price of 1.17.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LUNG Current Analyst RatingLUNG Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

LUNG Historical Analyst RatingsLUNG Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
LUNG was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LUNG.
In the previous month the buy percentage consensus was at a similar level.
LUNG was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05D. Boral CapitalMaintains Buy -> Buy
2026-03-05Canaccord GenuityMaintains Buy -> Buy
2026-02-20D. Boral CapitalMaintains Buy -> Buy
2025-11-13D. Boral CapitalMaintains Buy -> Buy
2025-10-28D. Boral CapitalMaintains Buy -> Buy
2025-10-28Lake StreetMaintains Buy -> Buy
2025-09-08D. Boral CapitalMaintains Buy -> Buy
2025-08-01Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-07-31D. Boral CapitalMaintains Buy -> Buy
2025-07-31Lake StreetMaintains Buy -> Buy
2025-07-31StifelMaintains Buy -> Buy
2025-07-31Piper SandlerDowngrade Overweight -> Neutral
2025-05-22CitigroupMaintains Neutral -> Neutral
2025-05-01D. Boral CapitalMaintains Buy -> Buy
2025-05-01Canaccord GenuityMaintains Buy -> Buy
2025-05-01Piper SandlerReiterate Overweight -> Overweight
2025-03-11D. Boral CapitalMaintains Buy -> Buy
2025-03-10D. Boral CapitalInitiate Buy
2024-12-11Wells FargoMaintains Equal-Weight -> Equal-Weight
2024-12-11CitigroupDowngrade Buy -> Neutral
2024-10-31StifelMaintains Buy -> Buy
2024-08-01Wells FargoMaintains Equal-Weight -> Equal-Weight
2024-08-01Canaccord GenuityMaintains Buy -> Buy
2024-06-04Lake StreetInitiate Buy
2024-05-02Canaccord GenuityMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 28, 2026
Period
Q1 / 2026
EPS Estimate
-$0.33
Revenue Estimate
20.841M
Revenue Q2Q
-7.53%
EPS Q2Q
7.44%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-7.75%
Revenue (3 Months)
-7.75%
EPS (1 Month)
3.92%
EPS (3 Months)
3.92%

Next Earnings Summary

LUNG is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is -0.33 USD and the consensus revenue estimate is 20.84M USD.
The next earnings revenue estimate has been revised downward by 7.75% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
LUNG revenue by date.LUNG revenue by date.
68.675M
27.98%		83.789M
22.01%		90.497M
8.01%		92.738M
2.48%		109.86M
18.46%		158.23M
44.03%		278.94M
76.29%		374.45M
34.24%		649.93M
73.57%		755.79M
16.29%		880.46M
16.50%
EBITDA
YoY % growth
LUNG ebitda by date.LUNG ebitda by date.
-60.387M
-5.70%		-54.511M
9.73%		-50.709M
6.97%		-32.266M
36.37%		-19.477M
39.64%		-37.434M
-92.20%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
LUNG ebit by date.LUNG ebit by date.
-61.935M
-5.62%		-56.004M
9.58%		-51.763M
7.57%		-46.8M
9.59%		-36.145M
22.77%		-28.458M
21.27%		75.462M
365.17%		143.78M
90.53%		361.02M
151.09%		437.07M
21.07%		527.67M
20.73%
Operating Margin
LUNG operating margin by date.LUNG operating margin by date.
-90.19%-66.84%-57.20%-50.46%-32.90%-17.99%27.05%38.40%55.55%57.83%59.93%
EPS
YoY % growth
LUNG eps by date.LUNG eps by date.
-1.60
-0.63%		-1.40
12.50%		-1.33
5.00%		-1.36
-2.46%		-1.05
22.90%		-0.21
80.26%		1.56
850.12%		2.85
82.95%		6.86
141.22%		7.81
13.82%		8.97
14.75%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.33
7.44%		-0.28
25.74%		-0.29
15.00%		-0.26
-2.00%		-0.23
31.12%		-0.23
18.68%		-0.24
17.06%		-0.23
10.00%
Revenue
Q2Q % growth		20.841M
-7.53%		22.866M
-4.16%		23.538M
9.47%		25.437M
12.56%		23.164M
11.15%		25.347M
10.85%		25.959M
10.29%		28.631M
12.56%
EBITDA
Q2Q % growth		-7.659M
46.38%		-4.9M
65.56%		-6.026M
55.59%		-5.401M
22.27%		-4.291M
43.97%		-3.319M
32.26%		-3.658M
39.30%		-1.895M
64.91%
EBIT
Q2Q % growth		-13.223M
9.20%		-11.468M
22.54%		-11.734M
18.48%		-10.391M
-29.84%		-10.647M
19.49%		-9.685M
15.55%		-10.034M
14.49%		-8.281M
20.31%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LUNG Yearly Revenue VS EstimatesLUNG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
LUNG Yearly EPS VS EstimatesLUNG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.63%
EPS Next 5 Year
32.86%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
20.03%
Revenue Next 5 Year
32.55%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
11.40%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PULMONX CORP / LUNG Forecast FAQ

What is the price target for LUNG stock?

12 analysts have analysed LUNG and the average price target is 5.27 USD. This implies a price increase of 350.43% is expected in the next year compared to the current price of 1.17.

Can you provide the upcoming earnings date for PULMONX CORP?

PULMONX CORP (LUNG) will report earnings on 2026-04-28, after the market close.

Can you provide the consensus estimates for PULMONX CORP next earnings?

The consensus EPS estimate for the next earnings of PULMONX CORP (LUNG) is -0.33 USD and the consensus revenue estimate is 20.84M USD.

Can you provide the consensus rating for PULMONX CORP stock?

The consensus rating for PULMONX CORP (LUNG) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.